Suppr超能文献

高效抗逆转录病毒治疗(HAART)长期治疗后外周血CD4淋巴细胞和单核细胞中总HIV-1 DNA与整合HIV-1 DNA的比较分析

Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART.

作者信息

Calcaterra S, Cappiello G, Di Caro A, Garbuglia A R, Benedetto A

机构信息

Laboratory of Virology, L. Spallanzani Hospital IRCCS, Rome, Italy.

出版信息

J Infect. 2001 Nov;43(4):239-45. doi: 10.1053/jinf.2001.0875.

Abstract

OBJECTIVE

To determine the level of total and integrated HIV-1 DNA load in CD4 lymphocytes and monocytes of patients undergoing HAART treatment for at least 2 years.

METHODS

CD4 lymphocytes were isolated by subjecting monocyte-depleted blood samples to immune-purging carried out with M-450 Dynabeads. Monocytes were separated by blood through a combined procedure of cell adherence to dishes and complement induced immune lysis with anti-CD3 Mab. HIV DNA in CD4 lymphocytes and monocytes was quantified by polymerase chain reaction (PCR) based limit dilution assay with two PCR protocols, specific for total (LTR PCR) and integrated (Alu PCR) forms of HIV DNA. The replication competence of the provirus harboured in monocyte-depleted peripheral blood mononuclear cells (PBMC) and adherent monocytes was assayed by measuring HIV-1 p24 antigen produced by in-vitro cultures established with these cells.

RESULTS

The CD4 lymphocytes of all patients contained a consistent number of HIV DNA copies. Most patients were also positive for HIV DNA in monocytes. The Alu PCR analysis detected, integrated provirus in CD4 lymphocytes of 9 patients and in the monocytes of only three. Four patients had replication-competence virus in their PBL. The monocytes of all patients did not produce virus in vitro.

CONCLUSION

The HIV infection of CD4 lymphocytes and monocytes is maintained even after HAART related, apparent, and durable suppression of viral replication. We suggest that the viral persistent infection of monocytes may play a role in maintaining the residual HIV activity found in patients undergoing HAART.

摘要

目的

确定接受高效抗逆转录病毒治疗(HAART)至少2年的患者CD4淋巴细胞和单核细胞中HIV-1 DNA的总量及整合量水平。

方法

通过使用M-450 Dynabeads进行免疫清除,从去除单核细胞的血样中分离CD4淋巴细胞。通过细胞贴壁培养皿和用抗CD3单克隆抗体诱导补体免疫裂解的联合程序从血液中分离单核细胞。采用基于聚合酶链反应(PCR)的极限稀释法,使用两种针对HIV DNA总量(LTR PCR)和整合形式(Alu PCR)的PCR方案,对CD4淋巴细胞和单核细胞中的HIV DNA进行定量。通过测量用这些细胞建立的体外培养物产生的HIV-1 p24抗原,检测去除单核细胞的外周血单核细胞(PBMC)和贴壁单核细胞中携带的前病毒的复制能力。

结果

所有患者的CD4淋巴细胞中HIV DNA拷贝数一致。大多数患者的单核细胞中HIV DNA也呈阳性。Alu PCR分析在9例患者的CD4淋巴细胞和仅3例患者的单核细胞中检测到整合的前病毒。4例患者的外周血淋巴细胞中有具有复制能力的病毒。所有患者的单核细胞在体外均未产生病毒。

结论

即使在HAART导致病毒复制明显且持久受到抑制之后,CD4淋巴细胞和单核细胞的HIV感染仍持续存在。我们认为,单核细胞的病毒持续感染可能在维持接受HAART治疗的患者中发现的残余HIV活性方面发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验